Tarsus Pharmaceuticals Inc (TARS)
36.19
+0.41
(+1.15%)
USD |
NASDAQ |
May 23, 16:00
36.19
0.00 (0.00%)
After-Hours: 20:00
Tarsus Pharmaceuticals Market Cap: 1.367B for May 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 22, 2024 | 1.352B |
| May 21, 2024 | 1.429B |
| May 20, 2024 | 1.463B |
| May 17, 2024 | 1.445B |
| May 16, 2024 | 1.458B |
| May 15, 2024 | 1.455B |
| May 14, 2024 | 1.435B |
| May 13, 2024 | 1.450B |
| May 10, 2024 | 1.398B |
| May 09, 2024 | 1.286B |
| May 08, 2024 | 1.411B |
| May 07, 2024 | 1.437B |
| May 06, 2024 | 1.399B |
| May 03, 2024 | 1.392B |
| May 02, 2024 | 1.308B |
| May 01, 2024 | 1.227B |
| April 30, 2024 | 1.187B |
| April 29, 2024 | 1.213B |
| April 26, 2024 | 1.210B |
| April 25, 2024 | 1.217B |
| April 24, 2024 | 1.238B |
| April 23, 2024 | 1.273B |
| April 22, 2024 | 1.220B |
| April 19, 2024 | 1.225B |
| April 18, 2024 | 1.241B |
| Date | Value |
|---|---|
| April 17, 2024 | 1.300B |
| April 16, 2024 | 1.318B |
| April 15, 2024 | 1.320B |
| April 12, 2024 | 1.365B |
| April 11, 2024 | 1.445B |
| April 10, 2024 | 1.354B |
| April 09, 2024 | 1.369B |
| April 08, 2024 | 1.329B |
| April 05, 2024 | 1.311B |
| April 04, 2024 | 1.319B |
| April 03, 2024 | 1.354B |
| April 02, 2024 | 1.343B |
| April 01, 2024 | 1.353B |
| March 28, 2024 | 1.363B |
| March 27, 2024 | 1.296B |
| March 26, 2024 | 1.269B |
| March 25, 2024 | 1.278B |
| March 22, 2024 | 1.260B |
| March 21, 2024 | 1.262B |
| March 20, 2024 | 1.265B |
| March 19, 2024 | 1.182B |
| March 18, 2024 | 1.148B |
| March 15, 2024 | 1.184B |
| March 14, 2024 | 1.104B |
| March 13, 2024 | 1.176B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
267.80M
Minimum
May 04 2022
1.463B
Maximum
May 20 2024
573.14M
Average
491.47M
Median
Market Cap Benchmarks
| Pacira BioSciences Inc | 1.414B |
| Unicycive Therapeutics Inc | 36.43M |
| CEL-SCI Corp | 67.70M |
| AIM ImmunoTech Inc | 20.51M |
| IGC Pharma Inc | 31.13M |
Market Cap Related Metrics
| PEG Ratio | -0.0804 |
| Price to Book Value | 4.968 |
| Price | 36.19 |
| Earnings Yield | -13.18% |
| PEGY Ratio | -0.0804 |